{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:28:09Z","timestamp":1785605289640,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/gt.2015.64","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T14:40:57Z","timestamp":1435675257000},"page":"856-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression"],"prefix":"10.1038","volume":"22","author":[{"given":"C","family":"Unzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Herv\u00e1s-Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Manche\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Morales-Kastresana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Serrano-Mendioroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"de Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fontanellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"BFgt201564_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10545-005-8050-3","volume":"28","author":"MN Badminton","year":"2005","unstructured":"Badminton MN, Elder GH . Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis 2005; 28: 277\u2013286.","journal-title":"J Inherit Metab Dis"},{"key":"BFgt201564_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2007-1007139","volume":"18","author":"UA Meyer","year":"1998","unstructured":"Meyer UA, Schuurmans MM, Lindberg RL . Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998; 18: 43\u201352.","journal-title":"Semin Liver Dis"},{"key":"BFgt201564_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"H Puy","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC . Porphyrias. Lancet 2010; 375: 924\u2013937.","journal-title":"Lancet"},{"key":"BFgt201564_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","volume":"142","author":"KE Anderson","year":"2005","unstructured":"Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142: 439\u2013450.","journal-title":"Ann Intern Med"},{"key":"BFgt201564_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mt.2010.210","volume":"19","author":"C Unzu","year":"2011","unstructured":"Unzu C, Sampedro A, Mauleon I, Alegre M, Beattie SG, de Salamanca RE et al. Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice. Mol Ther 2011; 19: 243\u2013250.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR6","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1093\/hmg\/ddt148","volume":"22","author":"C Unzu","year":"2013","unstructured":"Unzu C, Sampedro A, Mauleon I, Gonzalez-Aparicio M, Enriquez de Salamanca R, Prieto J et al. Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice. Hum Mol Genet 2013; 22: 2929\u20132940.","journal-title":"Hum Mol Genet"},{"key":"BFgt201564_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/mt.2009.250","volume":"18","author":"M Yasuda","year":"2010","unstructured":"Yasuda M, Bishop DF, Fowkes M, Cheng SH, Gan L, Desnick RJ . AAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function. Mol Ther 2010; 18: 17\u201322.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ymthe.2004.05.018","volume":"10","author":"A Johansson","year":"2004","unstructured":"Johansson A, Nowak G, Moller C, Blomberg P, Harper P . Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria. Mol Ther 2004; 10: 337\u2013343.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1824-7288-34-2","volume":"34","author":"N Brunetti-Pierri","year":"2008","unstructured":"Brunetti-Pierri N . Gene therapy for inborn errors of liver metabolism: progress towards clinical applications. Ital J Pediatr 2008; 34: 2.","journal-title":"Ital J Pediatr"},{"key":"BFgt201564_CR10","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.2174\/138161211797247604","volume":"17","author":"SC Gordts","year":"2011","unstructured":"Gordts SC, Van Craeyveld E, Jacobs F, De Geest B . Gene transfer for inherited metabolic disorders of the liver: immunological challenges. Curr Pharm Des 2011; 17: 2542\u20132549.","journal-title":"Curr Pharm Des"},{"key":"BFgt201564_CR11","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1093\/hmg\/ddr143","volume":"20","author":"N Brunetti-Pierri","year":"2011","unstructured":"Brunetti-Pierri N, Ng P . Helper-dependent adenoviral vectors for liver-directed gene therapy. Hum Mol Genet 2011; 20: R7\u201313.","journal-title":"Hum Mol Genet"},{"key":"BFgt201564_CR12","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","volume":"78","author":"DA Muruve","year":"2004","unstructured":"Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T et al. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J Virol 2004; 78: 5966\u20135972.","journal-title":"J Virol"},{"key":"BFgt201564_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/gt.2008.14","volume":"15","author":"N Brunetti-Pierri","year":"2008","unstructured":"Brunetti-Pierri N, Ng P . Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors. Gene Therapy 2008; 15: 553\u2013560.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.gt.3302819","volume":"14","author":"K Oka","year":"2007","unstructured":"Oka K, Belalcazar LM, Dieker C, Nour EA, Nuno-Gonzalez P, Paul A et al. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Therapy 2007; 14: 191\u2013202.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/hum.2013.071","volume":"24","author":"N Brunetti-Pierri","year":"2013","unstructured":"Brunetti-Pierri N, Ng T, Iannitti D, Cioffi W, Stapleton G, Law M et al. Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors. Hum Gene Ther 2013; 24: 761\u2013765.","journal-title":"Hum Gene Ther"},{"key":"BFgt201564_CR16","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","volume":"96","author":"N Morral","year":"1999","unstructured":"Morral N, O'Neal W, Rice K, Leland M, Kaplan J, Piedra PA et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci USA 1999; 96: 12816\u201312821.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201564_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/sj.mt.6300102","volume":"15","author":"N Brunetti-Pierri","year":"2007","unstructured":"Brunetti-Pierri N, Stapleton GE, Palmer DJ, Zuo Y, Mane VP, Finegold MJ et al. Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther 2007; 15: 732\u2013740.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR18","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/mt.2012.143","volume":"20","author":"N Brunetti-Pierri","year":"2012","unstructured":"Brunetti-Pierri N, Liou A, Patel P, Palmer D, Grove N, Finegold M et al. Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaques. Mol Ther 2012; 20: 1863\u20131870.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/gt.2009.148","volume":"17","author":"S Nayak","year":"2010","unstructured":"Nayak S, Herzog RW . Progress and prospects: immune responses to viral vectors. Gene Therapy 2010; 17: 295\u2013304.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/156652311796150372","volume":"11","author":"YS Ahi","year":"2011","unstructured":"Ahi YS, Bangari DS, Mittal SK . Adenoviral vector immunity: its implications and circumvention strategies. Curr Gene Ther 2011; 11: 307\u2013320.","journal-title":"Curr Gene Ther"},{"key":"BFgt201564_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA . Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346\u2013358.","journal-title":"Nat Rev Genet"},{"key":"BFgt201564_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/mt.2008.37","volume":"16","author":"AP McCaffrey","year":"2008","unstructured":"McCaffrey AP, Fawcett P, Nakai H, McCaffrey RL, Ehrhardt A, Pham TT et al. The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver. Mol Ther 2008; 16: 931\u2013941.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/156652311796150363","volume":"11","author":"R Khare","year":"2011","unstructured":"Khare R, Chen CY, Weaver EA, Barry MA . Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 2011; 11: 241\u2013258.","journal-title":"Curr Gene Ther"},{"key":"BFgt201564_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","volume":"363","author":"ZF Soonawalla","year":"2004","unstructured":"Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004; 363: 705\u2013706.","journal-title":"Lancet"},{"key":"BFgt201564_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/lt.21261","volume":"13","author":"AK Seth","year":"2007","unstructured":"Seth AK, Badminton MN, Mirza D, Russell S, Elias E . Liver transplantation for porphyria: who, when, and how? Liver Transpl 2007; 13: 1219\u20131227.","journal-title":"Liver Transpl"},{"key":"BFgt201564_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/lt.22345","volume":"18","author":"JK Dowman","year":"2012","unstructured":"Dowman JK, Gunson BK, Mirza DF, Bramhall SR, Badminton MN, Newsome PN . Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis. Liver Transpl 2012; 18: 195\u2013200.","journal-title":"Liver Transpl"},{"key":"BFgt201564_CR27","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/j.1432-2277.2009.01035.x","volume":"23","author":"S Wahlin","year":"2010","unstructured":"Wahlin S, Harper P, Sardh E, Andersson C, Andersson DE, Ericzon BG . Combined liver and kidney transplantation in acute intermittent porphyria. Transpl Int 2010; 23: e18\u2013e21.","journal-title":"Transpl Int"},{"key":"BFgt201564_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/gt.2010.125","volume":"18","author":"H Cao","year":"2011","unstructured":"Cao H, Yang T, Li XF, Wu J, Duan C, Coates AL et al. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression. Gene Therapy 2011; 18: 173\u2013181.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR29","first-page":"496","volume":"3","author":"TA Smith","year":"1996","unstructured":"Smith TA, White BD, Gardner JM, Kaleko M, McClelland A . Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Therapy 1996; 3: 496\u2013502.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/156652306776359478","volume":"6","author":"DS Bangari","year":"2006","unstructured":"Bangari DS, Mittal SK . Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther 2006; 6: 215\u2013226.","journal-title":"Curr Gene Ther"},{"key":"BFgt201564_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.gt.3302152","volume":"11","author":"H Haegel-Kronenberger","year":"2004","unstructured":"Haegel-Kronenberger H, Haanstra K, Ziller-Remy C, Ortiz Buijsse AP, Vermeiren J, Stoeckel F et al. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys. Gene Therapy 2004; 11: 241\u2013252.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/mt.2009.312","volume":"18","author":"A Fontanellas","year":"2010","unstructured":"Fontanellas A, Hervas-Stubbs S, Mauleon I, Dubrot J, Mancheno U, Collantes M et al. Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates. Mol Ther 2010; 18: 754\u2013765.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/hep.21292","volume":"44","author":"J Crettaz","year":"2006","unstructured":"Crettaz J, Berraondo P, Mauleon I, Ochoa-Callejero L, Shankar V, Barajas M et al. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice. Hepatology 2006; 44: 623\u2013632.","journal-title":"Hepatology"},{"key":"BFgt201564_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/hgtb.2013.108","volume":"24","author":"N Pastore","year":"2013","unstructured":"Pastore N, Nusco E, Piccolo P, Castaldo S, Vanikova J, Vetrini F et al. Improved efficacy and reduced toxicity by ultrasound-guided intrahepatic injections of helper-dependent adenoviral vector in Gunn rats. Hum Gene Ther Methods 2013; 24: 321\u2013327.","journal-title":"Hum Gene Ther Methods"},{"key":"BFgt201564_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/hum.2006.17.391","volume":"17","author":"N Brunetti-Pierri","year":"2006","unstructured":"Brunetti-Pierri N, Ng T, Iannitti DA, Palmer DJ, Beaudet AL, Finegold MJ et al. Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primates. Hum Gene Ther 2006; 17: 391\u2013404.","journal-title":"Hum Gene Ther"},{"key":"BFgt201564_CR36","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1128\/JVI.01392-12","volume":"87","author":"R Khare","year":"2013","unstructured":"Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA . Circulating antibodies and macrophages as modulators of adenovirus pharmacology. J Virol 2013; 87: 3678\u20133686.","journal-title":"J Virol"},{"key":"BFgt201564_CR37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.3107","volume":"19","author":"Z Xu","year":"2013","unstructured":"Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T et al. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med 2013; 19: 452\u2013457.","journal-title":"Nat Med"},{"key":"BFgt201564_CR38","doi-asserted-by":"publisher","first-page":"11705","DOI":"10.1128\/JVI.01320-08","volume":"82","author":"Z Xu","year":"2008","unstructured":"Xu Z, Tian J, Smith JS, Byrnes AP . Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol 2008; 82: 11705\u201311713.","journal-title":"J Virol"},{"key":"BFgt201564_CR39","doi-asserted-by":"publisher","first-page":"e85432","DOI":"10.1371\/journal.pone.0085432","volume":"9","author":"C Unzu","year":"2014","unstructured":"Unzu C, Melero I, Morales-Kastresana A, Sampedro A, Serrano-Mendioroz I, Azpilikueta A et al. Innate functions of immunoglobulin M lessen liver gene transfer with helper-dependent adenovirus. PLoS One 2014; 9: e85432.","journal-title":"PLoS One"},{"key":"BFgt201564_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1479-5876-10-122","volume":"10","author":"C Unzu","year":"2012","unstructured":"Unzu C, Hervas-Stubbs S, Sampedro A, Mauleon I, Mancheno U, Alfaro C et al. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates. J Transl Med 2012; 10: 122.","journal-title":"J Transl Med"},{"key":"BFgt201564_CR41","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1089\/hum.2013.166","volume":"24","author":"A Paneda","year":"2013","unstructured":"Paneda A, Lopez-Franco E, Kaeppel C, Unzu C, Gil-Royo AG, D'Avola D et al. Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria. Hum Gene Ther 2013; 24: 1007\u20131017.","journal-title":"Hum Gene Ther"},{"key":"BFgt201564_CR42","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1089\/10430349950016852","volume":"10","author":"FA Nunes","year":"1999","unstructured":"Nunes FA, Furth EE, Wilson JM, Raper SE . Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. Hum Gene Ther 1999; 10: 2515\u20132526.","journal-title":"Hum Gene Ther"},{"key":"BFgt201564_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/10430340152712692","volume":"13","author":"N Morral","year":"2002","unstructured":"Morral N, O'Neal WK, Rice K, Leland MM, Piedra PA, Aguilar-Cordova E et al. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther 2002; 13: 143\u2013154.","journal-title":"Hum Gene Ther"},{"key":"BFgt201564_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymgme.2008.12.016","volume":"96","author":"JM Wilson","year":"2009","unstructured":"Wilson JM . Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Mol Genet Metab 2009; 96: 151\u2013157.","journal-title":"Mol Genet Metab"},{"key":"BFgt201564_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/mt.2008.257","volume":"17","author":"N Brunetti-Pierri","year":"2009","unstructured":"Brunetti-Pierri N, Stapleton GE, Law M, Breinholt J, Palmer DJ, Zuo Y et al. Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol Ther 2009; 17: 327\u2013333.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.exger.2014.04.004","volume":"55","author":"HY Zheng","year":"2014","unstructured":"Zheng HY, Zhang MX, Pang W, Zheng YT . Aged Chinese rhesus macaques suffer severe phenotypic T- and B-cell aging accompanied with sex differences. Exp Gerontol 2014; 55: 113\u2013119.","journal-title":"Exp Gerontol"},{"key":"BFgt201564_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0022-1759(82)90170-3","volume":"50","author":"LN Martin","year":"1982","unstructured":"Martin LN . Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using deae cellulose and protein A-sepharose. J Immunol Methods 1982; 50: 319\u2013329.","journal-title":"J Immunol Methods"},{"key":"BFgt201564_CR48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4049\/jimmunol.106.1.246","volume":"106","author":"RT Damian","year":"1971","unstructured":"Damian RT, Greene ND, Kalter SS . IgG subclasses in the baboon (Papio cynocephalus. J Immunol 1971; 106: 246\u2013257.","journal-title":"J Immunol"},{"key":"BFgt201564_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2567.2004.01767.x","volume":"111","author":"F Scinicariello","year":"2004","unstructured":"Scinicariello F, Engleman CN, Jayashankar L, McClure HM, Attanasio R . Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions. Immunology 2004; 111: 66\u201374.","journal-title":"Immunology"},{"key":"BFgt201564_CR50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/CDLI.6.6.953-958.1999","volume":"6","author":"MH Shearer","year":"1999","unstructured":"Shearer MH, Dark RD, Chodosh J, Kennedy RC . Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol 1999; 6: 953\u2013958.","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFgt201564_CR51","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/mt.2011.71","volume":"19","author":"R Khare","year":"2011","unstructured":"Khare R, May SM, Vetrini F, Weaver EA, Palmer D, Rosewell A et al. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Mol Ther 2011; 19: 1254\u20131262.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/mthe.2000.0227","volume":"3","author":"N Tao","year":"2001","unstructured":"Tao N, Gao GP, Parr M, Johnston J, Baradet T, Wilson JM et al. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 2001; 3: 28\u201335.","journal-title":"Mol Ther"},{"key":"BFgt201564_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.imlet.2009.06.003","volume":"125","author":"R Racine","year":"2009","unstructured":"Racine R, Winslow GM . IgM in microbial infections: taken for granted? Immunol Lett 2009; 125: 79\u201385.","journal-title":"Immunol Lett"},{"key":"BFgt201564_CR54","first-page":"3","volume-title":"The Liver: Biology and Pathobiology","author":"JW Grisham","year":"2009","unstructured":"Grisham JW . Organizational principles of the liver. In: Arias IM (ed). The Liver: Biology and Pathobiology, 5th edn. John Wiley & Sons Ltd.: : Chichester, West Sussex, UK, 2009, pp 3\u201316."},{"key":"BFgt201564_CR55","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/gt.2011.58","volume":"18","author":"M Gonzalez-Aparicio","year":"2011","unstructured":"Gonzalez-Aparicio M, Mauleon I, Alzuguren P, Bunuales M, Gonzalez-Aseguinolaza G, San Martin C et al. Self-inactivating helper virus for the production of high-capacity adenoviral vectors. Gene Therapy 2011; 18: 1025\u20131033.","journal-title":"Gene Therapy"},{"key":"BFgt201564_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/10430340460732445","volume":"15","author":"N Brunetti-Pierri","year":"2004","unstructured":"Brunetti-Pierri N, Palmer DJ, Beaudet AL, Carey KD, Finegold M, Ng P . Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 2004; 15: 35\u201346.","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201564","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T22:09:52Z","timestamp":1691791792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFgt201564"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.64","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]},"assertion":[{"value":"13 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}